Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

Necrostatin 2

Name: Necrostatin 2
Brand: TargetMol
SKU: T12203L
Rating: 4.5 (1 reviews)

Copy Product Info

😃Good

Catalog No. T12203LCas No. 852391-19-6

Alias Necrostatin2

Necrostatin 2 is a necrotic protein and receptor-interacting protein kinase 1 (RIPK1) inhibitor used to study inner ear disorders such as sudden deafness, dizziness and tinnitus.

Necrostatin 2

Copy Product Info

😃Good

Purity: 99.92%

Catalog No. T12203LAlias Necrostatin2Cas No. 852391-19-6

Necrostatin 2 is a necrotic protein and receptor-interacting protein kinase 1 (RIPK1) inhibitor used to study inner ear disorders such as sudden deafness, dizziness and tinnitus.

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
5 mg	$500	5 days	5 days
10 mg	$900	7-10 days	7-10 days

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.92%

Appearance:Solid

Color:White

Resource Download

COA

Product Introduction

Bioactivity

Description	Necrostatin 2 is a necrotic protein and receptor-interacting protein kinase 1 (RIPK1) inhibitor used to study inner ear disorders such as sudden deafness, dizziness and tinnitus.
Targets&IC50	Jurkat cells (FADD-deficient human ):50 nM(EC50)
In vitro	Necrostatin 2 displays activity in a broad range of necroptosis cellular systems. [1] Necrostatin 2 at 30 μM fully protects L929 cells from TNF-α-induced necroptosis. [2] Necrotic apoptosis inhibitory activity was assessed by treating FADD-deficient human Jurkat T cells with TNF-α. Utilizing these conditions the cells efficiently undergo necroptosis, which is completely and selectively inhibited by Necrostatin 2 (EC50=50 nM). [3]
Synonyms	Necrostatin2

Chemical Properties

Molecular Weight	277.71
Formula	C₁₃H₁₂ClN₃O₂
Cas No.	852391-19-6
Smiles	C(C=1C=2C(NC1)=C(Cl)C=CC2)[C@@H]3C(=O)N(C)C(=O)N3
Relative Density.	1.450 g/cm3 (Predicted)

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 80 mg/mL (288.07 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.88 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.6009 mL	18.0044 mL	36.0088 mL	180.0439 mL
5 mM	0.7202 mL	3.6009 mL	7.2018 mL	36.0088 mL
10 mM	0.3601 mL	1.8004 mL	3.6009 mL	18.0044 mL
20 mM	0.1800 mL	0.9002 mL	1.8004 mL	9.0022 mL
50 mM	0.0720 mL	0.3601 mL	0.7202 mL	3.6009 mL
100 mM	0.0360 mL	0.1800 mL	0.3601 mL	1.8004 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc